Form 483

Cabell Huntington Hospital dba Center for Reproductive Medicine Form 483, 2022-08-18

FDA issued a Form 483 to Cabell Huntington Hospital dba Center for Reproductive Medicine on 2022-08-18 with 4 public-safe observations.

483· Form 483 issuedBiologics4 observations

Cabell Huntington Hospital dba Center for Reproductive Medicine · Huntington, United States · Issued August 18, 2022

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

18 Aug 2022
21 CFR 1271.47(a)

Testing, screening, donor eligibility procedures

Cited by Carl E Lovrich

18 Aug 2022
21 CFR 1271.75(a)(1)

Risk factors, clinical evidence

Cited by Carl E Lovrich

18 Aug 2022
21 CFR 1271.80(c)

Kits not FDA approved, specifically labeled

Cited by Carl E Lovrich

18 Aug 2022
21 CFR 1271.85(a)

Infection with communicable disease agents

Cited by Carl E Lovrich

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 1271.47(a)Cited across public-safe Form 483 observations1x
21 CFR 1271.75(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 1271.80(c)Cited across public-safe Form 483 observations1x
21 CFR 1271.85(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 4 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere